APA
Maher T. M., Corte T. J., Fischer A., Kreuter M., Lederer D. J., Molina-Molina M., Axmann J., Kirchgaessler K. & Cottin V. (2018). Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial. : BMJ open respiratory research.
Chicago
Maher Toby M, Corte Tamera J, Fischer Aryeh, Kreuter Michael, Lederer David J, Molina-Molina Maria, Axmann Judit, Kirchgaessler Klaus-Uwe and Cottin Vincent. 2018. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial. : BMJ open respiratory research.
Harvard
Maher T. M., Corte T. J., Fischer A., Kreuter M., Lederer D. J., Molina-Molina M., Axmann J., Kirchgaessler K. and Cottin V. (2018). Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial. : BMJ open respiratory research.
MLA
Maher Toby M, Corte Tamera J, Fischer Aryeh, Kreuter Michael, Lederer David J, Molina-Molina Maria, Axmann Judit, Kirchgaessler Klaus-Uwe and Cottin Vincent. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial. : BMJ open respiratory research. 2018.